Geneticin, G-418 Sulfate (A2513): Precision Selection & Anti
2026-05-29
This article delineates key laboratory challenges in genetic engineering and antiviral research, demonstrating how Geneticin, G-418 Sulfate (SKU A2513) delivers reproducible results and workflow reliability. Evidence-backed scenarios address protocol optimization, data interpretation, and vendor selection, positioning this compound as an essential tool for rigorous cell-based assays.
Cyanine 5-dCTP: Redefining Enzymatic DNA Fluorescent Labelin
2026-05-28
Explore how Cyanine 5-dCTP enables precise, high-yield fluorescent DNA labeling for next-generation enzymatic synthesis and molecular assays. This article reveals new insights into DNA framework innovations and practical protocol design.
SGI-1027 and Everolimus Induce Synergistic Cell Death in RCC
2026-05-28
This study reveals that SGI-1027, a DNA methyltransferase inhibitor, triggers methuosis and potentiates everolimus-induced cytotoxicity in renal cancer by promoting lysosomal membrane permeability and activating apoptosis and pyroptosis. The findings highlight a novel combinatorial strategy to overcome resistance in advanced renal cell carcinoma.
Periodontopathogen Proteases Generate Angiotensin (1-7) from
2026-05-27
This study uncovers a novel mechanism by which Porphyromonas gingivalis and Tannerella forsythia, key periodontopathogens, degrade angiotensin I to produce Angiotensin (1-7) via unique surface proteases. The findings highlight a direct microbial modulation of the renin–angiotensin system, reshaping our understanding of oral-systemic disease links and the local anti-inflammatory landscape.
Redefining Precision: EZ Cap™ Cas9 mRNA (m1Ψ) in Translation
2026-05-27
This thought-leadership article demystifies the mechanistic strengths and strategic value of EZ Cap™ Cas9 mRNA (m1Ψ) for translational researchers. By integrating the latest advances in mRNA engineering—including Cap1 capping, N1-Methylpseudo-UTP modification, and poly(A) tailing—with emerging science on mRNA nuclear export modulation, we provide a comprehensive guide for maximizing specificity, efficiency, and safety in mammalian genome editing workflows. Strategic recommendations are anchored in pivotal literature and benchmarked against the evolving competitive landscape, positioning APExBIO’s solution as a central driver of next-generation gene editing.
NAT10-Driven ac4C RNA Modification Regulates Mouse Oocyte Ma
2026-05-26
This study uncovers the role of NAT10-mediated N4-acetylcytidine (ac4C) RNA modification in controlling post-transcriptional regulation during in vitro maturation of mouse oocytes. By demonstrating that NAT10 knockdown impairs oocyte meiotic progression and identifying TBL3 as a potential ac4C-binding protein, the work deepens our understanding of epitranscriptomic mechanisms in reproductive biology.
SGI-1027: Unlocking Selective Epigenetic Reprogramming in Ca
2026-05-26
Explore how SGI-1027, a potent DNA methyltransferase inhibitor, enables selective reactivation of silenced tumor suppressor genes in cancer research. This article offers fresh insight into its mechanism, advanced applications, and practical assay optimization strategies.
p-Cresyl Sulfate: From Uremic Biomarker to Experimental Cata
2026-05-25
Explore the multifaceted role of p-Cresyl sulfate in cardiovascular and renal research. This article reveals unique mechanistic insights and advanced assay strategies, making it an essential resource for endothelial dysfunction research.
Maraviroc (UK-427857): Optimizing CCR5 Antagonism in HIV and
2026-05-25
Maraviroc (UK-427857) empowers researchers to precisely dissect CCR5-mediated mechanisms in both HIV-1 entry inhibition and neuroinflammation studies. This guide details experimental workflows, cross-domain innovations, and practical troubleshooting—ensuring robust, reproducible results for HIV tropism and ischemic stroke models.
HyperScribe T7 High Yield RNA Synthesis Kit: Precision for C
2026-05-24
The HyperScribe™ T7 High Yield RNA Synthesis Kit streamlines high-yield, customizable in vitro RNA synthesis for advanced molecular research. Robust enough for RNA modification studies, vaccine workflows, or functional genomics assays, it delivers reliable performance and workflow clarity for bench scientists.
Scalable hiPSC-Derived Human Sensory Neuron Model for HSV-1
2026-05-23
This study establishes a robust, scalable protocol for differentiating human inducible pluripotent stem cells (hiPSCs) into sensory neurons suitable for modeling herpes simplex virus 1 (HSV-1) latent infection and reactivation. The findings enable detailed investigation of neuron-intrinsic mechanisms underlying HSV-1 latency in a human context, addressing a critical gap left by animal models.
Angiotensin Peptides Modulate SARS-CoV-2 Spike–Receptor Bind
2026-05-22
This study demonstrates that naturally occurring angiotensin peptides, particularly certain truncated forms, enhance the binding of the SARS-CoV-2 spike protein to its cellular receptors, especially AXL. Findings provide new insight into the interplay between the renin-angiotensin system and COVID-19 pathogenesis, highlighting potential targets for therapeutic intervention.
QRICH1 Drives ER Stress–Mediated HMGB1 Secretion in HBV Fibr
2026-05-22
This study reveals QRICH1 as a pivotal mediator of endoplasmic reticulum (ER) stress that enhances HBV-driven HMGB1 translocation and secretion in hepatocytes, promoting hepatic fibrosis. These findings clarify molecular mechanisms underlying HBV-induced liver injury and provide a foundation for refining experimental fibrosis models.
RNA Pol II Degradation Triggers Apoptosis Independently of T
2026-05-21
Harper et al. (2025) reveal that cell death following RNA Pol II inhibition is not a passive consequence of transcriptional shutdown, but an active, mitochondria-mediated apoptotic response triggered by the loss of hypophosphorylated RNA Pol IIA. This insight reframes how transcriptional inhibitors function in cancer research and highlights a novel pathway for apoptosis induction.
(-)-JQ1: Precision Control for BET Bromodomain Assays
2026-05-21
(-)-JQ1, the gold-standard inactive JQ1 stereoisomer, is essential for dissecting on-target effects in BET bromodomain inhibition studies. Its use as a negative control elevates reproducibility and specificity, especially in complex epigenetics and cancer biology research involving BRD4 pathways.
556 records 17/38 page Previous Next First page 上5页 1617181920 下5页 Last page